SEARCH

Entries in Prevnar (2)

Friday
Dec302011

Prevnar 13 FDA-Approved for Adults 50 and Older

PRNewsFoto/Amgen/Hemera/Thinkstock(NEW YORK) -- The pneumococcal vaccine Prevnar 13 has been approved by the FDA for use in adults ages 50 and over, Pfizer said Friday.

"Pneumococcal disease, including pneumonia, in adults 50 years and older represents a significant personal and societal health burden in the United States. The FDA approval of Prevnar 13 for these adults offers the potential to contribute to the health of millions of aging Americans,” Ian Read, chairman and chief executive officer of Pfizer Inc. said in a statement Friday.

According to Pfizer, Pneumococcal disease (PD) is growing as a leading public health issue for adults 50 and older in the U.S., where there are "hundreds of thousands of S. pneumoniae infections per year, including more than 440,000 cases of pneumococcal pneumonia, accounting for an estimated 200,000 emergency department visits and 300,000 hospitalizations."

“Clearly, there remains a high incidence of pneumococcal pneumonia in this adult population,” said Emilio Emini, Ph.D., chief scientific officer, Vaccine Research for Pfizer. “Prevnar 13 was licensed for adults 50 years and older by the FDA under an accelerated approval pathway because of its potential to help address this significant disease burden.”

Previously Prevnar's use in the U.S. was limited to the prevention and treatment of ear infections, sepsis and meningitis in children, the Wall Street Journal reports.

Copyright 2011 ABC News Radio

Tuesday
Mar082011

Pediatric Vaccines Still Under Suspension in Japan

Creatas Images/Thinkstock(TOKYO) -- Japanese health officials have announced Tuesday that they would continue the suspension of two pediatric vaccines following reports that four children had died shortly after immunizations had been administered.

Japan's Ministry of Health, Labor and Welfare assembled a panel of experts, which found no evidence of a causal relationship between Pfizer's Prevnar and Sanofi Pasteur's ActHIB but said more analysis may be necessary.

The ministry suspended use of both vaccines Monday after the deaths, which occurred last week. 

All four children reportedly received Prevnar and only three had been given ActHIB.

Both manufacturers of the suspended vaccinations are cooperating with the investigation.

Copyright 2011 ABC News Radio







ABC News Radio